KID syndrome: Histopathological, immunohistochemical and molecular analysis of precancerous and cancerous skin lesions

British Journal of Dermatology

Volumn 166, Issue 2, 2012, Pages 455-457

  Bergman, R ^a   Mercer, A ^a   Indelman, M ^a   Sprecher, E ^a   Haim, N ^a   Zoller, L ^a   Ben Izhak, O ^a   Hershkovitz, D ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CONNEXIN 26; DNA; KI 67 ANTIGEN; UVOMORULIN;

BACTERIAL INFECTION; DARIER DISEASE; DISEASE PREDISPOSITION; DNA SEQUENCE; HEARING IMPAIRMENT; HISTOPATHOLOGY; HUMAN; ICHTHYOSIS; IMMUNOHISTOCHEMISTRY; KERATITIS; LETTER; MISSENSE MUTATION; MYCOSIS; POLYMERASE CHAIN REACTION; PRECANCER; PRIORITY JOURNAL; SKIN CANCER; SKIN CARCINOMA; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; SYNDROME KID; TONGUE CARCINOMA;

BIOPSY; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CODON, NONSENSE; DEAFNESS; GENES, P53; HETEROZYGOTE; HUMANS; ICHTHYOSIS; IMMUNOHISTOCHEMISTRY; KERATITIS; MUTATION, MISSENSE; PRECANCEROUS CONDITIONS; SKIN NEOPLASMS;

EID: 84856216351     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10577.x     Document Type: Letter

References (10)

1. Nyquist GG, Mumm C, Grau R, et al. Malignant proliferating pilar tumors arising in KID syndrome: a report of two patients. Am J Med Genet 2007; 143: 734-41.
2. Momiyama M, Omori Y, Ishizaki Y, et al. Connexin 26-mediated gap junctional communication reverses the malignant phenotype of MCF-7 breast cancer cells. Cancer Sci 2003; 94: 501-7.
3. Baden HP, Alper JC,. Ichthyosiform dermatosis, keratitis, and deafness. Arch Dermatol 1977; 113: 1701-4.
4. Madariaga J, Fromowitz F, Phillips M, et al. Squamous cell carcinoma in congenital ichthyosis with deafness and keratitis. A case report and review of the literature. Cancer 1986; 57: 2026-9.
5. van Steensel MA, van Geel M, Nahuys M, et al. A novel connexin 26 mutation in a patient diagnosed with keratitis-ichthyosis-deafness syndrome. J Invest Dermatol 2002; 18: 724-7.
6. Bumroongkit K, Rannala B, Traisathit P, et al. TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors. Cancer Genet Cytogenet 2008; 185: 20-7.
7. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38: 357-61.
8. Hsiesh LL, Wang PF, Chen IH, et al. Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in Taiwanese. Carcinogenesis 2001; 22: 1497-503.
9. Conway K, Edmiston SN, Cui L, et al. Prevalence and spectrum of p53 mutations associated with smoking in breast cancer. Cancer Res 2002; 62: 1987-95.
10. Ide F, Kitada M, Sakashita H, et al. p53 haploinsufficiency profoundly accelerates the onset of tongue tumors in mice lacking the xeroderma pigmentosum group A gene. Am J Pathol 2003; 163: 1729-33.